availability

Avail Bio is a venture-backed genomic biotechnology company based in San Francisco, California, that focuses on precision oncology. The company leverages proprietary genomic platform technologies to optimize patient responses to cancer therapeutics while minimizing the risk of adverse events. Founded with support from the Illumina Accelerator, Avail Bio integrates advanced data and software solutions to better understand the immune system and drive the discovery of next-generation immunotherapies. Its mission is to push the boundaries of immune therapeutic discovery through a deep understanding of individual patient genomics.